Icos Binding Proteins
GlaxoSmithKline Intellectual Property Development Limited
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/247,355, filed Oct 28, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,738,718 | Icos Binding Proteins In force · High confidence UsedRemaining | GlaxoSmithKline Intellectual Property Development Limited | In force | High confidence | ||
| US 9,771,424 | Icos Binding Proteins In force · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | High confidence | ||
| US 11,130,811 | Icos Binding Proteins In force · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | High confidence | ||
| US 10,351,627 | Icos Binding Proteins In force · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | High confidence | ||
| Application 15/649,791 | Icos Binding Proteins Abandoned Abandoned Jun 6, 2018 | GlaxoSmithKline Intellectual Property Development Limited | Abandoned | Abandoned Jun 6, 2018 | ||
| Application 15/987,996 | Icos Binding Proteins Abandoned Abandoned Aug 20, 2020 | GlaxoSmithKline Intellectual Property Development Limited | Abandoned | Abandoned Aug 20, 2020 | ||
| Application 16/440,137 | Icos Binding Proteins Abandoned Abandoned Sep 3, 2020 | GlaxoSmithKline Intellectual Property Development Limited | Abandoned | Abandoned Sep 3, 2020 | ||
| Application 17/412,614 | Icos Binding Proteins Abandoned Abandoned Dec 26, 2024 | GlaxoSmithKline Intellectual Property Development Limited | Abandoned | Abandoned Dec 26, 2024 |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by GlaxoSmithKline Intellectual Property Development Limited.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.